[Skip to Content]

Upstate Active Clinical Trials

Study Title:

Alliance A151216 - Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)

What is the purpose of the study?

This research trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.

Upstate Institutional Review Board (IRB) Number:

652783

Study/Protocol ID:

A151216

Study Phase:

N/A

Patient Age Group:

Adults

Principal Investigator:

Stephen L Graziano, MD

Where will the study take place?

Upstate Cancer Center-All procedures

ClinicalTrials.Gov ID:

NCT02194738

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Erinn Mcdowell, MS, CCRP
Phone: 315-464-8230
Email: mcdowele@upstate.edu

Return to Previous Page || Search Again

Top